Treatment of copper deficient buffaloes through the application of parenteral copper

The objective of this study was to investigate the effectiveness of the treatment of copper deficiency, by parenteral route, in buffalo calves raised on the Marajó Island (PA). Fourteen animals were divided into two groups. Group 1 received three doses of 120 mg of copper glycinate (20mgCu/mL), intramuscularly, on days 1, 45 and 90; in the group 2 (control) the animals were Not supplemented with copper. In both groups liver biopsies were performed on days 1 and 135. The diagnosis of copper deficiency was established through history, clinical signs, and by the analysis of hepatic copper content. In group 1, the mean hepatic copper content increased from 17.4±5.84mg/kgDM (before administration) to 311.2±133.5mg/kgDM (after 135 days) (P